The drug, one of the few nonhormonal options for menopausal women, reduced hot flashes and night sweats, and appears to help ...
The U.S. Food and Drug Administration has approved British drugmaker GSK's blood cancer drug, Blenrep, in one combination regimen, the company said on Thursday, clearing the way for its return to the ...
A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer ...
Opioids were once the go-to solution for surgical pain relief, but unwanted side effects like nausea, dizziness, constipation ...
A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...
MedPage Today on MSN
New Drug for Rare Neuroendocrine Tumors Shows Durable Activity
BERLIN -- Belzutifan (Welireg) induced durable responses in advanced pheochromocytoma or paraganglioma (PPGL) in a single-arm ...
A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...
New website, TrueWeed.org, launches a broad initiative to empower young people to make healthy, science-based decisions about ...
The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback